SynthesisPharmacoEconomics2014

Model-based cost-effectiveness analyses for the treatment of chronic lymphocytic leukaemia: a review of methods to model disease outcomes and estimate utility.

Kevin Marsh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.